SELVAS Healthcare, Inc. (KOSDAQ:208370)

South Korea · Delayed Price · Currency is KRW

2,455.00

+65.00 (2.72%)

At close: Aug 24, 2026

-38.39% (1Y)

Market Cap	61.47B -40.8%
Revenue (ttm)	30.19B -6.1%
Net Income	16.92B +527.1%
EPS	645.99 +510.2%
Shares Out	25.72M
PE Ratio	3.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	295,775
Open	2,390.00
Previous Close	2,390.00
Day's Range	2,390.00 - 2,635.00
52-Week Range	2,130.00 - 7,490.00
Beta	-0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SELVAS Healthcare

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, the company provides daisy players, handheld, and desktop magnifiers. Its products are used in hospitals, medical facilities, doctor's offices, weight loss cent... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1993

Employees 128

Stock Exchange KOSDAQ

Ticker Symbol 208370

Full Company Profile

Financial Performance

In 2025, SELVAS Healthcare's revenue was 30.82 billion, a decrease of -2.77% compared to the previous year's 31.70 billion. Earnings were 3.89 billion, an increase of 23.39%.

Financial Statements